FDA Approves First Nonsteroidal Drug for DMD
U.S. Food and Drug Administration
The FDA granted the approval of Duvyzat™ to Italfarmaco S.p.A
Disease Treatment
Treatments for Long COVID-Related Neurological Symptoms in Trials
National Institutes of Health
Trials will test at least three treatments for long COVID symptoms, such as fast heart rate, dizziness, and fatigue
AI-Based Personalized Therapies Need Agile Approval Processes
Dresden University of Technology
Commercializing AI-based treatment warrants regulatory changes and multilayered testing and monitoring approaches
3D Printed Tissue Model Could Aid Liver Disease Research
Sanford Burnham Prebys Medical Discovery Institute
MASH is expected to surpass hepatitis C as the main cause of liver transplantation in the US
Harnessing the Power of Molecular Testing for GI Disease Diagnostics and Treatment
Thermo Fisher Scientific
Empowering health care begins with advanced molecular testing options and comprehensive management strategies
Predictive Algorithms Not Robust Enough for Clinical Research
Yale University
Algorithms need to be built and trained on real-world inconsistencies and shared data sets to be generalizable
New Test Drug–Empagliflozin Combo Abates CKD Side Effects
UW Medicine
Some 70 percent of patients who received the test drug with a standard-care drug experienced a significant drop in albuminuria
World-First Human Trial Offers New Type 1 Diabetes Treatment
St Vincent’s Institute of Medical Research
A commonly prescribed rheumatoid arthritis drug may suppress the progression of type 1 diabetes
Unlock the Potential of T-Cell Profiling
Bruker
IsoSpark™ and Beacon® platforms offer a robust solution to unravel the complexities of individual T-cell function
US Newborn Syphilis Cases See 10x Spike Over a Decade
Centers for Disease Control and Prevention
Almost 9 in 10 newborn syphilis cases in 2022 might have been prevented with timely testing and treatment during pregnancy